期刊文献+

稳定表达绿色荧光蛋白标记的人单纯疱疹病毒2型潜伏相关转录体ORF2融合蛋白的Vero细胞株的建立 被引量:1

Establishment of Vero Cell Strain for Stable Expression of Fusion Protein of Open Reading Frame 2 of Human Herpes Simplex Virus Type 2 Latency Associated Transcript and Enhanced Green Fluorescent Protein
原文传递
导出
摘要 目的建立稳定表达绿色荧光蛋白(EGFP)标记的人单纯疱疹病毒2型(HSV-2)潜伏相关转录体(LAT)开放读码框2(ORF2)融合蛋白的Vero细胞株。方法构建重组真核表达质粒pEGFP-ORF2,经酶切及测序鉴定正确后,体外转染Vero细胞,经G418筛选稳定表达融合蛋白的克隆,扩大培养后,荧光显微镜观察EGFP的表达,RT-PCR检测目的基因的转录。结果重组真核表达质粒pEGFP-ORF2经酶切及测序鉴定构建正确,经G418培养20d筛选出的Vero细胞株荧光显微镜下可见融合蛋白表达,RT-PCR检测显示,转染了重组表达质粒的Vero细胞内有目的基因的表达。结论已成功建立了稳定表达EGFP-ORF2的Vero细胞株,为进一步研究HSV-2LATORF2的功能奠定了基础。 Objective To establish a Vero cell strain for stable expression of fusion protein of open reading frame 2(ORF2) of human herpes simplex virus type 2(HSV-2)latency associated transcript(LAT)and enhanced green fluorescent protein(EGFP).Methods Recombinant plasmid pEGFP-ORF2 was constructed and identified by restriction analysis and sequencing,then transfected to Vero cells in vitro.The recombinants for stable expression of fusion protein were screened with G418 for scale-up culture,in which the expression of EGFP was observed by fluorescent microscopy,and the transcription of target gene by RT-PCR.Results Both restriction analysis and sequencing proved that recombinant plasmid pEGFP-ORF2 was constructed correctly.The expression of fusion protein was proved by fluorescent microscopy in the screened Vero cell strain.RT-PCR showed transcription of target gene in Vero cells transfected with recombinant plasmid pEGFP-ORF2.Conclusion A Vero cells strain for stable expression of fusion protein of HSV-2 LAT ORF2 and EGFP was successfully established,which laid a foundation of further study on function of HSV-2 LAT ORF2.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第6期566-568,共3页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(30972666) 全军医药卫生科研基金资助项目(06J008)
关键词 疱疹病毒2型 潜伏相关转录体 开放读码框2 绿色荧光蛋白质类 VERO细胞 Herpes virus type 2 human Latency associated transcript(LAT) Open reading frame 2(ORF2) Green fluorescent proteins Vero cells
  • 相关文献

参考文献9

  • 1Kent JR, Kang W, Miller CG, et al. Herpes simplex virus latencyassociated transcript gene function [J]. J Neurovirol, 2003, 9 (3): 285-290.
  • 2Jin L, Carpenter D, Moerdyk-Schauwecker M, et al. Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice [J]. J Neurovirul, 2008, 14 (5): 389-400.
  • 3Carpenter D, Henderson G, Hsiang C, et al. Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity [J]. Microb Pathog, 2008, 44 (2): 98-102.
  • 4Branco FJ, Fraser NW. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis [J]. J Virol, 2005, 79 (14): 9019-9025.
  • 5仕瑶慧,樊建勇,杨慧兰.潜伏相关转录体在单纯疱疹病毒中的作用[J].国际皮肤性病学杂志,2006,32(5):324-326. 被引量:5
  • 6Derfuss T, Arbusow V, Strupp M, et al. The presence of lytic HSV- 1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia [J]. Ann N Y Acad Sci, 2009, 1164: 300-304.
  • 7Shen W, Sa e Silva M, Jaber T, et al. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis [J]. J Virol, 2009, 83 (18): 9131- 9139.
  • 8Daly CJ, McGrath JC. Fluorescent ligands, antibodies, and proteins for the study of receptors [J]. Pharmacol Ther, 2003, 100 (2): 101-118.
  • 9何永林,朱道银,伊正君,杨春,徐蕾,王瑜伟.颗粒溶素活性肽与增强型绿色荧光蛋白融合基因真核表达质粒的构建及其在小鼠黑色素瘤细胞中的表达[J].中国生物制品学杂志,2008,21(12):1043-1046. 被引量:2

二级参考文献24

  • 1伊正君,朱道银,李俊明,何永林,杨健,李娜.人颗粒溶素与EGFP基因融合表达载体的构建及其在鼠巨噬细胞RAW264.7中的表达[J].第四军医大学学报,2005,26(23):2125-2128. 被引量:3
  • 2Huang LP, Lyu SC, Clayberger C, et al. Granulysin-mediated tumor rejection in transgenic mice. J Immunol, 2007, 178 ( 1 ): 77-84.
  • 3Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science, 1998, 282 (5386): 121-125.
  • 4Clayberger C, Krensky AM. Granulysin. Curr Opin Immunol, 2003, 15(5): 560- 565.
  • 5Ogawa K, Takamori Y, Suzuki K, et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol, 2003, 33 (7): 1925-1933.
  • 6Saigusa S, Ichikura T, Tsujimoto H, et al. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma. J Gastroenterol Hepatol, 2007, 22(8): 1322-1327.
  • 7Pena SV, Krensky AM. Granulysin, a new human cytolytic granuleassociated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol, 1997, 9(2): 117-125.
  • 8Pena SV, Hanson DA, Carr BA, et al. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol, 1997, 158(6): 2680-2688.
  • 9Sekiya M, Ohwada A, Katae M, et al. Adenovirus vector-mediated transfer of 9 kDa granulysin induces DNA fragmentation in HuD antigen-expressing small cell lung cancer murine model ceils. Respirology, 2002, 7( 1 ): 29-35.
  • 10Hanson DA, Ziegler SF. Fusion of green fluorescent protein to the C-terminus of granulysin alters its intracellular localization in comparison to the native molecule. J Negat Results Biomed, 2004, 3 (1): 2.

共引文献5

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部